33P Changes in serum cytokine CXCL12 level can predict the survival of patients with non-small cell lung cancer receiving anti-PD-1 treatment. (December 2022) - Xu, Y.; Li, H.; Huang, Z.; Xie, M.; Zhou, Z.; Fan, Y.